scholarly article | Q13442814 |
P356 | DOI | 10.1038/KI.1993.114 |
P698 | PubMed publication ID | 8479116 |
P2093 | author name string | M Parker | |
H D Feiner | |||
L D Dworkin | |||
J A Benstein | |||
E Tolbert | |||
P2860 | cites work | Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis | Q69590785 |
Studies on binding and mitogenic effect of insulin and insulin-like growth factor I in glomerular mesangial cells | Q70054389 | ||
Amelioration of experimental glomerulonephritis by dietary protein restriction | Q71172944 | ||
The effects of nifedipine, a calcium antagonist, on platelet function | Q71729995 | ||
Development of glomerular lesions in experimental long-term diabetes in the rat | Q72112884 | ||
[A simple colorimetric method of inulin determination in renal clearance studies on metabolically normal subjects and diabetics] | Q73829329 | ||
Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat | Q28360398 | ||
Glomerular injury in uninephrectomized spontaneously hypertensive rats. A consequence of glomerular capillary hypertension | Q34526945 | ||
Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension | Q34610189 | ||
"Intact nephrons" as the primary origin of proteinuria in chronic renal disease. Study in the rat model of subtotal nephrectomy | Q35593027 | ||
Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension | Q36994591 | ||
Determination of serum protein concentration in nanoliter blood samples using fluorescamine or o-phthalaldehyde | Q39211382 | ||
Stereology: applications to biomedicalresearch | Q39995562 | ||
Effects of nifedipine and enalapril on glomerular structure and function in uninephrectomized SHR. | Q41161504 | ||
Renal vascular effects of antihypertensive therapy in uninephrectomized SHR. | Q41269304 | ||
Effects of salt restriction on renal growth and glomerular injury in rats with remnant kidneys | Q42092938 | ||
Long-term enalapril and verapamil in rats with reduced renal mass | Q44745481 | ||
Effect of tensile and shear stress on intimal permeability of the left coronary artery in dogs | Q47957639 | ||
Relation of kidney tissue somatomedin-C/insulin-like growth factor I to postnephrectomy renal growth in the rat. | Q54339186 | ||
Effects of some vasodilator drugs on transcapillary fluid exchange in renal cortex | Q67779371 | ||
Renal hemodynamic effects of calcium antagonists in rats with reduced renal mass | Q68206364 | ||
Comparison of converting enzyme inhibitor and calcium channel blocker in hypertensive glomerular injury | Q68554179 | ||
Verapamil protects against progression of experimental chronic renal failure | Q68968554 | ||
Effects of antihypertensive drugs on glomerular morphology | Q69358944 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 808-814 | |
P577 | publication date | 1993-04-01 | |
P1433 | published in | Kidney International | Q6404823 |
P1476 | title | Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms | |
P478 | volume | 43 |
Q57704296 | ACE inhibition prevents renal failure and death in uninephrectomized MWF/Ztm rats |
Q82449410 | Azelnidipine attenuates glomerular damage in Dahl salt-sensitive rats by suppressing sympathetic nerve activity |
Q74597349 | Beneficial effects of chronic administration of dietary omega-3 polyunsaturated fatty acids in dogs with renal insufficiency |
Q40053641 | Blood pressure influences end-stage renal disease of Cd151 knockout mice |
Q72822581 | Calcium blockade versus ACE inhibition in clipped and unclipped kidneys of 2K-1C rats |
Q33917790 | Calcium channel blockers - the effect on renal changes in clinical and experimental diabetes: an overview |
Q73162663 | Cardiovascular risk, renal hypertensive damage, and effects of amlodipine treatment in transgenic TGR(mREN2)27 rats |
Q38075788 | Cell-matrix adhesion of podocytes in physiology and disease |
Q35752310 | Deleterious effects of calcium channel blockade on pressure transmission and glomerular injury in rat remnant kidneys |
Q74764027 | Diabetic nephropathy |
Q72735503 | Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney |
Q41349603 | Endothelial function and the kidney. An emerging target for cardiovascular therapy |
Q74151922 | Influence of the timing of initiating antihypertensive therapy in hypertensive rats with renal failure |
Q50751783 | Inhibitory effect of calcium channel blockers on human mesangial cell growth: evidence for actions independent of L-type Ca2+ channels. |
Q41520406 | Kidney and Hypertension: Role of the Juxtaglomerular Apparatus |
Q54390737 | L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats. |
Q78035086 | Microalbuminuria in essential hypertension |
Q72822571 | Modulation of glomerular hypertension defines susceptibility to progressive glomerular injury |
Q41431049 | Prevention and slowing down the progression of the diabetic nephropathy through antihypertensive therapy |
Q74080676 | Renal effects of antihypertensive therapy in uninephrectomized diabetic rats |
Q33649627 | Renal protection and antihypertensive drugs: current status |
Q44629540 | Verapamil reverts acute renal functional impairment induced by angiotensin II converting enzyme inhibitors |